Patent court rules against Lilly in patent suit

Korea’s patent court on November 5 dismissed claims by Eli Lilly, one of the world’s largest drug companies, in a patent lawsuit against Hanmi Pharm over its generic antipsychotic drug.

Zyprexa (olanzapine) is an atypical antipsychotic approved for the treatment of schizophrenia and bipolar disorder. Olanzapine is structurally similar to clozapine, but is classified as a thienobenzodiazepine...